SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0000950170-24-073629
Filing Date
2024-06-14
Accepted
2024-06-14 16:05:39
Documents
73
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A phat-20231231.htm   iXBRL 10-K/A 1677381
2 EX-4.8 phat-ex4_8.htm EX-4.8 30015
3 EX-10.26 phat-ex10_26.htm EX-10.26 31740
4 EX-10.27 phat-ex10_27.htm EX-10.27 151422
5 EX-10.28 phat-ex10_28.htm EX-10.28 70756
6 EX-23.1 phat-ex23_1.htm EX-23.1 5987
7 EX-24.1 phat-ex24_1.htm EX-24.1 18468
8 EX-31.1 phat-ex31_1.htm EX-31.1 13865
9 EX-31.2 phat-ex31_2.htm EX-31.2 14228
10 EX-32.1 phat-ex32_1.htm EX-32.1 8073
11 EX-32.2 phat-ex32_2.htm EX-32.2 8373
12 EX-97 phat-ex97.htm EX-97 34413
  Complete submission text file 0000950170-24-073629.txt   9634426

Data Files

Seq Description Document Type Size
13 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT phat-20231231.xsd EX-101.SCH 1636962
77 EXTRACTED XBRL INSTANCE DOCUMENT phat-20231231_htm.xml XML 1595625
Mailing Address 100 CAMPUS DRIVE, SUITE 102 FLORHAM PARK NJ 07932
Business Address 100 CAMPUS DRIVE, SUITE 102 FLORHAM PARK NJ 07932 (877) 742-8466
Phathom Pharmaceuticals, Inc. (Filer) CIK: 0001783183 (see all company filings)

IRS No.: 824151574 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-39094 | Film No.: 241044715
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)